6-Amino-6-deoxy-L-galactose—Innovative probe reagent for glycobiology research 155299-74-3

6-Amino-6-deoxy-L-galactose is a key functionalized sugar derivative in the field of glycochemistry and metabolism research. As an important component of MetabolicProbe Reagents, it is gradually becoming a sophisticated tool for exploring cellular sugar metabolism pathways, glycoprotein functions and disease mechanisms. This compound introduces a reactive amino group through specific modification of natural L-galactose, thereby giving it unique labeling and tracking capabilities, and shows broad application prospects in basic science and translational medicine.

Chemical Information

Chemical name: 6-amino-6-deoxy-L-galactose

Common name: 6-Amino-6-deoxy-L-galactose

Chemical formula: C6H13NO5

Molecular weight: 179.17 g/mol

CAS number: 1155299-74-3

Category: Metabolic Probe Reagents

Structural features

6-Amino-6-deoxy-L-galactose is a structural analog of L-galactose. Its molecular design reflects the precise chemical modification concept:

Specific amino substitution: At the 6th carbon position of L-galactose, the original hydroxyl group is replaced by an amino group (-NH2) to form a 6-deoxy and amination structure. This change not only retains the basic skeleton of the galactose ring, but also introduces a highly reactive primary amino group.

Enhanced chemical accessibility: The introduction of amino groups makes the compound easy to combine with a variety of reporter molecules (such as fluorescent dyes, biotin or radioactive labels) through coupling reactions, thereby enabling visualization and quantitative analysis of metabolic pathways. At the same time, its L-configuration is relatively rare in nature, which helps reduce background interference and improve the specificity of the probe.

Metabolic compatibility: As a derivative of natural sugar, 6-amino-6-deoxy-L-galactose can be partially recognized and processed by intracellular sugar metabolism enzymes, thereby integrating into glycoconjugates (such as glycoproteins or glycolipids), simulating or interfering with the natural glycosylation process.

Main applications and advantages

Dynamic tracking tool for glucose metabolism pathways

In cell biology, abnormalities in glucose metabolism are closely related to various pathological conditions such as cancer, diabetes, and immune diseases. 6-Amino-6-deoxy-L-galactose can be used as a metabolic probe to monitor the activity and flow direction of L-galactose-related metabolic pathways in real time through chemical labeling methods. For example, in research on the synthesis of glycosaminoglycans (GAGs), this compound can be incorporated into polysaccharide chains such as chondroitin sulfate or heparin to help analyze their biosynthesis and degradation mechanisms and provide new insights into metabolic diseases.

Key reagents for glycoprotein engineering and cell surface labeling

Glycosylation is an important form of protein post-translational modification, affecting protein stability, localization and function. By conjugating the amino group with a fluorescent tag or affinity reagent, the compound can specifically label galactose-derived structures on the cell surface for flow cytometry, microscopic imaging or proteomic analysis. In antibody drug development, such probes can help optimize glycosylation patterns and enhance the potency and half-life of therapeutic molecules.

Research on pathogen-host interaction and infection model

Many pathogens (such as bacteria and viruses) exploit host sugar metabolism for infection and immune evasion. 6-Amino-6-deoxy-L-galactose can be used as a tool molecule to reveal the uptake and utilization mechanism of galactose derivatives by pathogens. In microbiology experiments, labeled probes are used to track the distribution of glycoconjugates during infection, providing a basis for the discovery of anti-infective drug targets.

Potential platform for tumor diagnosis and targeted therapy

Cancer cells often exhibit abnormal glucose metabolism and glycosylation characteristics, such as changes in the expression of galactose-related antigens. Probes derived from this compound can be used to develop new imaging agents or delivery systems to specifically recognize the tumor microenvironment. Combined with nanotechnology, such probes can assist in early diagnosis or achieve directional delivery of chemotherapy drugs, improving treatment accuracy.

Conclusion

Although 6-amino-6-deoxy-L-galactose has a simple structure, it carries the mission of deepening the scientific understanding of sugars. From the drawing of metabolic maps to the construction of disease models, from basic glycobiology to cutting-edge drug design, its role as a probe reagent is constantly expanding the boundaries of life sciences. With the advancement of glycochemistry and synthetic biology, this molecule will continue to empower researchers to decode the codes of life in dynamic metabolic networks and promote the advent of the era of precision medicine.

The above information is provided by the editor of KASONS and is for scientific research only.